Cornerstone Pharmaceuticals

A Singular Focus on Cancer Metabolism

  • About
    • Overview
    • Leadership
    • Non-Executive Directors
    • Advisory Board Members
  • Cancer Metabolism
    • Overview
    • Our Approach
  • Platforms & Pipelines
    • Pipeline
    • AEMD/CPI-613
    • Emulsiphan/EmPAC
  • Clinical Trials
  • News & Media
    • Press Releases
    • News Coverage
    • Press Kit
    • Press Contacts
    • Scientific Papers and Abstracts
  • Careers
  • Contact
Home > News & Media > News Coverage

News Coverage

September 2011 BioCentury: Powering down cancer

April 2011 BioPharm Insight: Cornerstone Pharmaceuticals to seek CRO bids for Phase II oncology trial; considering capital raise by end of year

March 2011 SciBX: Targeting T cell metabolism

December 2010 The New York Times: Fuel lines of tumors are new target

September 2010 Cornerstone featured in Start-Up Magazine profile

September 2010 Start Up magazine: Biotechs target cancer metabolism

August 2010 Drug Discovery News special report: Trends in cancer research

June 2010 NJBiz: Life Sciences Funding Clinical trials, new hires with tax credit

May 2010 Drug Discovery News: Cancer research turns a corner

September 2009 SBU Couple Develop Cancer Treatment Together

Next »
inner-8

Copyright 2012 © Cornerstone Pharmaceuticals, Inc. All Rights Reserved.Privacy Policy | Terms & Conditions

  • Home
  • About Us
    • Overview
    • Leadership
    • Non-Executive Directors
    • Advisory Board Members
  • Cancer Metabolism
    • Overview
    • Our Approach
  • Platforms & Pipelines
    • Pipeline
    • AEMD/CPI-613
    • Emulsiphan/EmPAC
  • Clinical Trials
  • News & Media
    • Press Releases
    • News Coverage
    • Press Kit
    • Press Contacts
    • Scientific Papers and Abstracts
  • Careers
  • Contact

Cornerstone Pharmaceuticals Using its profound and proprietary understanding of cancer metabolism,
Cornerstone is dedicated to revolutionizing the way cancer is treated.

Website Design by Jackrabbit Design

Follow us on Twitter